Blog

  • Julie Cooper – 2016 Parliamentary Question to the Department of Health

    Julie Cooper – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Julie Cooper on 2016-01-06.

    To ask the Secretary of State for Health, how much the NHS has spent on treating health problems associated with tuberculosis sclerosis in each year since 2010.

    George Freeman

    Data on the cost to the National Health Service of treating health problems associated with tuberous sclerosis are not collected centrally by NHS England.

  • Stephen Gethins – 2016 Parliamentary Question to the Department of Health

    Stephen Gethins – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Stephen Gethins on 2016-01-06.

    To ask the Secretary of State for Health, what steps he is taking to prepare for the outcome of the EU referendum.

    Jane Ellison

    The Government is fighting hard to fix the aspects of our European Union membership that cause so much frustration in Britain – so we get a better deal for Britain and secure our future. The Government is focused on delivering a successful renegotiation: it believes it can and will succeed in reforming and renegotiating our relationship with the EU.

  • Sadiq Khan – 2016 Parliamentary Question to the Department of Health

    Sadiq Khan – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Sadiq Khan on 2016-01-06.

    To ask the Secretary of State for Health, how many days of (a) acute and (b) non-acute delayed transfers of care there were in each health trust in London in each month since January 2010.

    Alistair Burt

    Official statistics for the number of days of acute and non-acute delayed transfers of care there were each month in each health trust in London since August 2010, are published monthly by NHS England on its website at the following address. This data was not collected prior to August 2010.

    https://www.england.nhs.uk/statistics/statistical-work-areas/delayed-transfers-of-care/

  • Helen Hayes – 2016 Parliamentary Question to the Department of Health

    Helen Hayes – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Helen Hayes on 2016-01-06.

    To ask the Secretary of State for Health, whether full funding for the implementation of the new access target for early intervention in psychosis is included in the Government’s commitment to an additional £600 million of funding for mental health in 2016-17.

    Alistair Burt

    No decision has yet been reached on how the additional £600 million of funding for mental health in 2016-17 will be allocated.

    A key element of achieving parity across mental and physical health care is in people having timely access to evidence-based and effective treatment.

    One focus of the first set of mental health standards for 2015/16 is that from 1 April 2016, 50% of people experiencing a first episode of psychosis are treated with a National Institute for Health and Care Excellence approved package of care within two weeks of referral. This is being supported by £40 million recurrent funding from NHS England to support delivery of the early intervention in psychosis (EIP) standard. Health Education England are focusing £5 million for workforce development towards meeting the EIP standard.

  • Margaret Ritchie – 2016 Parliamentary Question to the Department of Health

    Margaret Ritchie – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Margaret Ritchie on 2016-01-06.

    To ask the Secretary of State for Health, what recent discussions he has had with the National Council for Care Excellence on the development of a clinical guideline for pancreatic cancer; and if he will make a statement.

    George Freeman

    NHS England has asked the National Institute for Health and Care Excellence to develop a clinical guideline on the diagnosis and management of pancreatic cancer. The draft scope consultation is currently in progress and the anticipated publication date for the clinical guideline is January 2018.

  • Margaret Ritchie – 2016 Parliamentary Question to the Department of Health

    Margaret Ritchie – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Margaret Ritchie on 2016-01-06.

    To ask the Secretary of State for Health, what steps he is taking to ensure greater levels of genetic testing for cancer and ultra rare diseases; and if he will make a statement.

    George Freeman

    Data on existing levels of genetic testing are not held centrally by NHS England. The UK Genetic Testing Network is working with NHS England, the devolved administrations and the Health and Social Care Information Centre to collect and publish United Kingdom-wide data on molecular genetic testing activity. Data collection is expected to have been completed by the summer of 2016 with a full update prepared for publication by the end of the year.

    The creation of regional Genomic Medicine Centre as part of the 100,000 Genomes Project will significantly increase genomic testing capacity across the UK.

    The project aims to sequence 100,000 whole human genomes and covers patients with rare diseases, cancer and infectious diseases. There will be 75,000 participants in the project, 40,000 of which will be patients and 35,000 of which will be healthy relatives.

  • Margaret Ritchie – 2016 Parliamentary Question to the Department of Health

    Margaret Ritchie – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Margaret Ritchie on 2016-01-06.

    To ask the Secretary of State for Health, what recent discussions he has had with his counterparts in the devolved administrations on the implementation of the Rare Disease Strategy.

    George Freeman

    The implementation of the UK Rare Disease Strategy is monitored by the UK Rare Disease Forum which includes representatives from all the devolved administrations. The Forum will publish their first assessment of the progress made in implementing the UK Rare Disease Strategy at the end of February 2016.

    The Rare Diseases Advisory Group (RDAG) makes recommendations to NHS England and the devolved administrations of NHS Scotland, NHS Wales and NHS Northern Ireland on developing and implementing the strategy for rare diseases and highly specialised services. The membership of RDAG also includes representation from the devolved administrations – NHS Scotland, NHS Wales and NHS Northern Ireland.

  • Julie Cooper – 2016 Parliamentary Question to the Department of Health

    Julie Cooper – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Julie Cooper on 2016-01-06.

    To ask the Secretary of State for Health, how much is available to each NHS trust to fund new drugs and treatments assessed and recommended by NICE.

    George Freeman

    The Government believes that National Health Service commissioners and providers are best placed to decide how to allocate their budgets to deliver improvements in the outcomes for patients.

    There is no separately identified ring-fenced funding stream associated with drugs and treatments recommended by the National Institute for Health and Care Excellence (NICE). NHS commissioners are legally required to fund drugs and treatments recommended by NICE.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2016-01-06.

    To ask the Secretary of State for Health, how many Band 7 NHS psychologists were employed in each year since 2010-11.

    Ben Gummer

    The attached table shows the number of Band 7 clinical psychology staff employed in the National Health Service in England each year from September 2010 to September 2015. The figures are taken from the NHS hospital and community health services monthly workforce statistics, which are published by the Health and Social Care Information Centre.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2016-01-06.

    To ask the Secretary of State for Health, pursuant to the Answer of 9 November 2015 to Question 14919, what decisions have been made on how to spend the remaining funds that was allocated for perinatal mental health for 2015-16; and whether NHS England plans to spend the full £15 million allocation by the end of 2015-16.

    Alistair Burt

    The Budget in March 2015 and the Spending Review in November 2015 both recognised perinatal mental health services as a priority area for additional investment.

    On 11 January the Government set out an additional £290 million which will be made available over the next five years to 2020/21 to invest in perinatal mental health services. This builds on the initial investment announced at the Spring Budget, making a total investment from 2016/17 to 2020/21 of £350 million. This new funding, together with the recommendations of the forthcoming report of the independent Mental Health Taskforce, will enable NHS England to design a broader transformation programme to build capacity and capability in specialist perinatal mental health services, with the aim of enabling women in all areas of England to access NICE-concordant care by 2020/21.

    In the context of this planned broader programme, NHS England anticipates spending up to £5 million of the original 2015/16 funding of £15 million in this financial year, to lay the foundations for this longer-term work through targeted funding of activities to build capacity in specialist services. This will include, for example, a £1 million investment in strengthening clinical networks across the country. It is also expected to include providing national and regional benchmarking data and analytical support to regions, and developing clinical leadership capacity. Additional work will support both the development of specialist Mother and Baby Units in those regions identified as most in need of new services, and training and developing the perinatal workforce to build skills and capabilities within specialist teams.

    NHS England will work with partners over the coming months to develop the new programme for improving specialist perinatal mental health services. This will include setting detailed plans for how the additional investment will be targeted over the period to 2020/21.